Nuvectis Pharma, Inc. Common Stock (NVCT) stock analysis and AI prediction
The company facts of Nuvectis Pharma, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Nuvectis Pharma, Inc. Common Stock
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $682.3 million
- Size
- Small cap
- Employees
- 13
- Headquarters
- FORT LEE, NJ
- Listed since
- Feb. 4, 2022
- Website
- nuvectis.com
More Healthcare stocks
Other small cap stocks
Keep going
NVCT questions
What is the AI prediction for NVCT stock?
Each market day our model rates Nuvectis Pharma, Inc. Common Stock (NVCT) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the NVCT prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for NVCT?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see NVCT options?
The NVCT options page explains its calls, puts and Greeks. The full NVCT options chain, every strike and expiry, is in the OpPreds app.